Xenova out-licenses preclinical technology to Genentech
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 24 (Table of Contents)
Published: 2 May-2002
DOI: 10.3833/pdr.v2002.i24.1059 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Xenova licensed a preclinical technology to Genentech in a deal worth up to US$63 M to develop treatments within the multi-billion dollar autoimmune disease market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS